Search the collection

1,032 results for anlotinib

Sort by:

Sort by

Limit results to:

20 per page

1,032 results for anlotinib

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Anlotinib: First Global Approval
Author / Creator:Syed, Yahiya Y.
Publisher:Cham: Springer International Publishing
Journal title:Drugs (New York, N.Y.), 2018-07, Vol.78 (10), p.1057-1062
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703)
Author / Creator:Chi, Yihebali ; Shu, Yongqian ; Ba, Yi ; Bai, Yuxian ; Qin, Baoli ; Wang, Xiuwen ; Xiong, Jianping ; Xu, Nong ; Zhang, Helong ; Zhou, Jianfeng ; Xu, Jianming ; Cheng, Ying ; Feng, Jifeng ; Hu, Chunhong ; Chen, Yigui ; Chen, Zhendong ; Wang, Jufeng ; Dang, Chengxue ; Wang, Jianhong ; Wan, Yiye ; Tang, Yong ; Wang, Donglin ; liu, Jiang ; Wu, Minhui ; Deng, Yanhong ; Li, Xingwen ; Li, Yongqiang ; Dong, Jian ; Jiang, Da ; Li, Guisheng ; Wu, Qiong ; Li, Jin ; Qi, Yujuan ; Sun, Yongkun ; Cai, Jianqiang
Publisher:Hoboken, USA: John Wiley & Sons, Inc
Journal title:The oncologist (Dayton, Ohio), 2021-10, Vol.26 (10), p.e1693-e1703
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor
Author / Creator:Xie, Chengying ; Wan, Xiaozhe ; Quan, Haitian ; Zheng, Mingyue ; Fu, Li ; Li, Yun ; Lou, Liguang
Publisher:England: John Wiley & Sons, Inc
Journal title:Cancer science, 2018-04, Vol.109 (4), p.1207-1219
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesFull Text
Anlotinib as a molecular targeted therapy for tumors (Review)
Author / Creator:Gao, Yi ; Liu, Pengfei ; Shi, Ruihua
Publisher:Athens: Spandidos Publications
Journal title:Oncology letters, 2020-08, Vol.20 (2), p.1001-1014
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
Author / Creator:Shen, Guoshuang ; Zheng, Fangchao ; Ren, Dengfeng ; Du, Feng ; Dong, Qiuxia ; Wang, Ziyi ; Zhao, Fuxing ; Ahmad, Raees ; Zhao, Jiuda
Publisher:England: BioMed Central Ltd
Journal title:Journal of hematology and oncology, 2018-09, Vol.11 (1), p.120-11, Article 120
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3‐TACC3 Fusion and Recurrent Glioblastoma
Author / Creator:Wang, Yong ; Liang, Dandan ; Chen, Jimin ; Chen, Huan ; Fan, Rui ; Gao, Ye ; Gao, Yongsheng ; Tao, Rongjie ; Zhang, Henghui
Publisher:Hoboken, USA: John Wiley & Sons, Inc
Journal title:The oncologist (Dayton, Ohio), 2021-03, Vol.26 (3), p.173-177
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Exosomal miR-136-5p Derived from Anlotinib-Resistant NSCLC Cells Confers Anlotinib Resistance in Non-Small Cell Lung Cancer Through Targeting PPP2R2A Exosomal miR-136-5p Derived from Anlotinib-Resista...
Author / Creator:Gu G ; Hu C ; Hui K ; Zhang H ; Chen T ; Zhang X ; Jiang X
Publisher:Dove Medical Press
Journal title:International journal of nanomedicine, 2021-09, Vol.16, p.6329-6343
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
Response to chemotherapy combined with anlotinib plus anlotinib maintenance in intra-abdominal desmoplastic small round cell tumors (IADSRCT): a case report and literature review
Author / Creator:Cheng, Ke ; Liu, Xia ; Chen, Ye ; Zhou, Kexun ; Li, ZhiPing
Publisher:London: BioMed Central Ltd
Journal title:BMC gastroenterology, 2022-08, Vol.22 (1), p.1-388, Article 388
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
Exosomal miR-136-5p Derived from Anlotinib-Resistant NSCLC Cells Confers Anlotinib Resistance in Non-Small Cell Lung Cancer Through Targeting PPP2R2A
Author / Creator:Gu, Guoqing ; Hu, Chenxi ; Hui, Kaiyuan ; Zhang, Huiqin ; Chen, Ting ; Zhang, Xin ; Jiang, Xiaodong
Publisher:New Zealand: Dove Medical Press Limited
Journal title:International journal of nanomedicine, 2021-01, Vol.16, p.6329-6343
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
ArticlesPeer ReviewedFull Text
Anlotinib potentiates anti‐PD1 immunotherapy via transferrin receptor‐dependent CD8+ T‐cell infiltration in hepatocellular carcinoma
Author / Creator:Song, Fei ; Hu, Bo ; Liang, Xiao‐Liang ; Cheng, Jian‐Wen ; Wang, Cheng‐Gui ; Wang, Peng‐Xiang ; Wang, Tian‐Lun ; Tang, Peng‐Ju ; Sun, Hai‐Xiang ; Guo, Wei ; Zhou, Jian ; Fan, Jia ; Chen, Zhong ; Yang, Xin‐Rong
Publisher:United States: John Wiley & Sons, Inc
Journal title:Clinical and translational medicine, 2024-08, Vol.14 (8), p.e1738-n/a
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ArticlesPeer ReviewedFull Text
anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells
Author / Creator:Liu, Shaochuan ; Qin, Tingting ; Liu, Zhujun ; Wang, Jing ; Jia, Yanan ; Feng, Yingfang ; Gao, Yuan ; Li, Kai
Publisher:London: Nature Publishing Group UK
Journal title:Cell death & disease, 2020-05, Vol.11 (5), p.309, Article 309
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma
Author / Creator:Wang, Hai-ying ; Chu, Jun-feng ; Zhang, Peng ; Wang, Jia-qiang ; Yan, Zheng ; Yao, Shu-na ; Yao, Zhi-hua ; Liu, Yan-yan
Publisher:New Zealand: Dove Medical Press Limited
Journal title:OncoTargets and therapy, 2020-02, Vol.13, p.1561-1568
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
ArticlesPeer ReviewedFull Text
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)
Author / Creator:Han, Baohui ; Li, Kai ; Zhao, Yizhuo ; Li, Baolan ; Cheng, Ying ; Zhou, Jianying ; Lu, You ; Shi, Yuankai ; Wang, Zhehai ; Jiang, Liyan ; Luo, Yi ; Zhang, Yiping ; Huang, Cheng ; Li, Qiang ; Wu, Guoming
Publisher:London: Nature Publishing Group UK
Journal title:British journal of cancer, 2018-03, Vol.118 (5), p.654-661
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
ArticlesPeer ReviewedFull Text
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
Author / Creator:Song, Fei ; Hu, Bo ; Cheng, Jian-Wen ; Sun, Yun-Fan ; Zhou, Kai-Qian ; Wang, Peng-Xiang ; Guo, Wei ; Zhou, Jian ; Fan, Jia ; Chen, Zhong ; Yang, Xin-Rong
Publisher:London: Nature Publishing Group UK
Journal title:Cell death & disease, 2020-07, Vol.11 (7), p.573, Article 573
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
ArticlesPeer ReviewedFull Text
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer
Author / Creator:Yang, Yinli ; Li, Ling ; Jiang, Zhansheng ; Wang, Bin ; Pan, Zhanyu
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Cancer Immunology, Immunotherapy, 2020-12, Vol.69 (12), p.2523-2532
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
ArticlesPeer ReviewedFull Text
Anlotinib in recurrent or metastatic endometrial cancer
Author / Creator:Cui, Qingli ; Mao, Yuefeng ; Hu, Yanhui ; Ma, Dongyang ; Liu, Huaimin
Publisher:United States: BMJ Publishing Group Ltd
Journal title:International journal of gynecological cancer, 2022-09, Vol.32 (9), p.1147-1152
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
ArticlesPeer ReviewedFull Text
Efficacy and safety of anlotinib combined with PD‐1/PD‐L1 inhibitors as second‐line and subsequent therapy in advanced small‐cell lung cancer
Author / Creator:Yu, Lian ; Xu, Jianlin ; Qiao, Rong ; Han, Baohui ; Zhong, Hua ; Zhong, Runbo
Publisher:United States: John Wiley & Sons, Inc
Journal title:Cancer medicine (Malden, MA), 2023-03, Vol.12 (5), p.5372-5383
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
ArticlesPeer ReviewedFull Text
TGF-β Signaling Activation Confers Anlotinib Resistance in Gastric Cancer
Author / Creator:Chen, Jingde ; Hai, Yanan ; Hu, Qingqing ; Chen, Chen ; Jiang, Xiaohua ; Gao, Yong
Publisher:New York: Springer US
Journal title:Pharmaceutical research, 2023-03, Vol.40 (3), p.689-699
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
ArticlesPeer ReviewedFull Text
Radiotherapy plus temozolomide with or without anlotinib in H3K27M‐mutant diffuse midline glioma: A retrospective cohort study
Author / Creator:Liu, Chao ; Kuang, Shuwen ; Huang, Tianxiang ; Wu, Jun ; Zhang, Longbo ; Gong, Xuan
Publisher:England: John Wiley & Sons, Inc
Journal title:CNS neuroscience & therapeutics, 2024-04, Vol.30 (4), p.e14730-n/a
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
ArticlesPeer ReviewedFull Text
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial
Author / Creator:Huang, Jing ; Xiao, Juxiang ; Fang, Wentao ; Lu, Ping ; Fan, Qingxia ; Shu, Yongqian ; Feng, Jifeng ; Zhang, Shu ; Ba, Yi ; Zhao, Yang ; Liu, Ying ; Bai, Chunmei ; Bai, Yuxian ; Tang, Yong ; Song, Yan ; He, Jie
Publisher:United States: John Wiley & Sons, Inc
Journal title:Cancer medicine (Malden, MA), 2021-03, Vol.10 (5), p.1681-1689
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 1,032 results

Export record to excel

Export this record

Export record to excel

Anlotinib: First Global Approval

Export this record

Export record to excel

Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703)

Export this record

Export record to excel

Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor

Export this record

Export record to excel

Anlotinib as a molecular targeted therapy for tumors (Review)

Export this record

Export record to excel

Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development

Export this record

Export record to excel

Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3‐TACC3 Fusion and Recurrent Glioblastoma

Export this record

Export record to excel

Exosomal miR-136-5p Derived from Anlotinib-Resistant NSCLC Cells Confers Anlotinib Resistance in Non-Small Cell Lung Cancer Through Targeting PPP2R2A Exosomal miR-136-5p Derived from Anlotinib-Resista...

Export this record

Export record to excel

Response to chemotherapy combined with anlotinib plus anlotinib maintenance in intra-abdominal desmoplastic small round cell tumors (IADSRCT): a case report and literature review

Export this record

Export record to excel

Exosomal miR-136-5p Derived from Anlotinib-Resistant NSCLC Cells Confers Anlotinib Resistance in Non-Small Cell Lung Cancer Through Targeting PPP2R2A

Export this record

Export record to excel

Anlotinib potentiates anti‐PD1 immunotherapy via transferrin receptor‐dependent CD8+ T‐cell infiltration in hepatocellular carcinoma

Export this record

Export record to excel

anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells

Export this record

Export record to excel

Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma

Export this record

Export record to excel

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)

Export this record

Export record to excel

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma

Export this record

Export record to excel

Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer

Export this record

Export record to excel

Anlotinib in recurrent or metastatic endometrial cancer

Export this record

Export record to excel

Efficacy and safety of anlotinib combined with PD‐1/PD‐L1 inhibitors as second‐line and subsequent therapy in advanced small‐cell lung cancer

Export this record

Export record to excel

TGF-β Signaling Activation Confers Anlotinib Resistance in Gastric Cancer

Export this record

Export record to excel

Radiotherapy plus temozolomide with or without anlotinib in H3K27M‐mutant diffuse midline glioma: A retrospective cohort study

Export this record

Export record to excel

Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial

Refine your search